Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) Tax Provisions (2016 - 2023)

Wave Life Sciences (WVE) has disclosed Tax Provisions for 8 consecutive years, with -$700000.0 as the latest value for Q3 2023.

  • For Q3 2023, Tax Provisions changed N/A year-over-year to -$700000.0; the TTM value through Jun 2024 reached -$700000.0, down 202.79%, while the annual FY2023 figure was -$677000.0, 199.41% down from the prior year.
  • Tax Provisions hit -$700000.0 in Q3 2023 for Wave Life Sciences, down from $681000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $681000.0 in Q4 2022 and bottomed at -$841000.0 in Q4 2020.
  • Average Tax Provisions over 4 years is -$266000.0, with a median of -$452000.0 recorded in 2021.
  • Year-over-year, Tax Provisions soared 75.74% in 2021 and then skyrocketed 433.82% in 2022.
  • Wave Life Sciences' Tax Provisions stood at -$841000.0 in 2020, then skyrocketed by 75.74% to -$204000.0 in 2021, then surged by 433.82% to $681000.0 in 2022, then crashed by 202.79% to -$700000.0 in 2023.
  • According to Business Quant data, Tax Provisions over the past three periods came in at -$700000.0, $681000.0, and -$204000.0 for Q3 2023, Q4 2022, and Q4 2021 respectively.